Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Vista Bank marked its debut as a bond issuer on the Bucharest Stock Exchange (BVB). The bank listed its €17 million bond issue on the Regulated Market, consolidating its strategy to diversify funding sources through the capital market.
The Vega Ploiești Refinery, operated by Rompetrol Rafinare, has started producing hexane with a minimum purity of 60%, supporting polypropylene production and the food industry.
The EU's downward trend in transport costs ended abruptly in March 2026, with Romania emerging as one of the most heavily impacted member states.
Energy producer OMV Petrom and RNV Infrastructure have announced that three wind projects in Romania, with a total installed capacity of approximately 300 MW, are entering the execution phase following the final investment decision. The projects hold the necessary permits, with production expected to begin in stages from H1 2027.
Romania's budget deficit calculated according to the European ESA methodology has dropped from 9.3% of GDP in 2024 to 7.9% of GDP in 2025, representing a correction of 1.4 percentage points of GDP.